Cancer Immunology and Immunotherapies: Mechanisms That Affect Antitumor Immune Response and Treatment Resistance

Abstract

The past decade has seen immunotherapy rise to the forefront of cancer treatment [...]

Advancing Cancer Immunotherapy: From Molecular Mechanisms to Clinical Applications

“…In recent years, cancer immunotherapy research has made remarkable progress, completely transforming the cancer treatment landscape. In 2021, we proudly introduced the Special Issue “Cancer Immunology” in the journal Cancers , featuring a collection of 17 highly acclaimed research and review articles [ 1 ]. Building upon the success of this prior endeavor, we are excited to present this new Special Issue, which aims to delve deeper into the most recent advancements, state-of-the-art technologies, and prospects in fundamental cancer immunology, pre-clinical assessments, and clinical trials.…”

Editorial: Bioinformatics tools (and web server) for cancer biomarker development, volume II

“…Cancer immunotherapies have shown great benefits for multiple types of tumor, including LUAD, PAAD and BLAC Frontiers in Genetics frontiersin.org (Hayes, 2021;Zhao and Subramanian, 2021) (Anastasiadou et al, 2018). Xing et al used Cox regression analysis to identify three immune-related lncRNAs (AC124067.4, LINC02604, and MIR4435-2HG), which were correlated with OS in COAD patients, and might play a role in anti-tumor immunotherapy.…”

“…Cancer immunotherapies have shown great benefits for multiple types of tumor, including LUAD, PAAD and BLAC ( Hayes, 2021 ; Zhao and Subramanian, 2021 ). Immune-related bioinformatics analysis would facilitate the improved treatment of tumor patients, and is expected to find new therapeutic targets.…”